https://scholars.lib.ntu.edu.tw/handle/123456789/516911
標題: | Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis | 作者: | JENQ-WEN HUANG CHUNG-JEN YEN Wu H.-Y. CHIH-KANG CHIANG HUI-TENG CHENG Lien Y.-C. KUAN-YU HUNG TUN-JUN TSAI |
公開日期: | 2011 | 卷: | 31 | 期: | 4 | 起(迄)頁: | 252-258 | 來源出版物: | Blood Purification | 摘要: | Peritoneal fibrosis (PF), including simple sclerosis and encapsulating peritoneal sclerosis (EPS), is a serious complication in patients on long-term peritoneal dialysis. Tamoxifen has successfully been used in treating EPS; however, the mechanism of tamoxifen in treating EPS fibrosis disorders remains unclear. This study demonstrates a possible antifibrotic mechanism of tamoxifen. A bleach-induced PF rat model was applied as the in vivo treatment target. Tamoxifen was intraperitoneally injected daily to treat PF. The PF scores and thickness of the submesothelial zone over the liver surface were measured as indicators for the severity of PF. Human peritoneal mesothelial cells (HPMC) were used as an in vitro model to test the antifibrotic effect of tamoxifen. Gene expressions of transforming growth factors-β (TGF-β), connective tissue growth factor (CTGF) and collagen were investigated using quantitative polymerase chain reactions. In HPMC, tamoxifen showed paradoxical effects between collagen I and TGF-β. Tamoxifen also inhibited TGF-β-induced collagen and CTGF. The possible antifibrotic effect of tamoxifen is through inhibiting CTGF to block collagen synthesis, although it enhances TGF-β which increases fibrosis. These results provide a possible molecular mechanism for tamoxifen. Copyright ? 2011 S. Karger AG. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-78651400159&doi=10.1159%2f000322255&partnerID=40&md5=b57ec90d3f98e3e00c2c0b8c0d56b696 https://scholars.lib.ntu.edu.tw/handle/123456789/516911 |
ISSN: | 0253-5068 | DOI: | 10.1159/000322255 | SDG/關鍵字: | collagen type 1; connective tissue growth factor; tamoxifen; transforming growth factor beta; animal experiment; animal model; animal tissue; article; controlled study; disease severity; down regulation; gene expression; histopathology; human; human cell; in vitro study; in vivo study; male; mesothelium; mesothelium cell; nonhuman; peritoneal fibrosis; peritoneum cell; polymerase chain reaction; priority journal; protein synthesis inhibition; quantitative analysis; rat; thickness; Animals; Antineoplastic Agents, Hormonal; Cells, Cultured; Collagen Type I; Connective Tissue Growth Factor; Down-Regulation; Extracellular Matrix; Gene Expression Regulation; Humans; Male; Peritoneal Fibrosis; Rats; Rats, Wistar; Sodium Hypochlorite; Tamoxifen; Transforming Growth Factor beta |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。